Notable Analyst Rating Changes 08/20: (ONXX) (WY) (ANN) Upgraded; (RVBD) (GTXI) (XEL) Downgraded
Tweet Send to a Friend
UPGRADES
Maxim Group raises Onyx Pharmaceuticals (Nasdaq: ONXX) from Hold to Buy with a price target of $130. Click ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Maxim Group raises Onyx Pharmaceuticals (Nasdaq: ONXX) from Hold to Buy with a price target of $130. Click ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
